Reliq Health Technologies (OTCMKTS:RQHTF) and DarioHealth (NASDAQ:DRIO) Critical Contrast

DarioHealth (NASDAQ:DRIOGet Free Report) and Reliq Health Technologies (OTCMKTS:RQHTFGet Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Earnings & Valuation

This table compares DarioHealth and Reliq Health Technologies”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DarioHealth $22.36 million 2.49 -$41.71 million ($6.13) -1.24
Reliq Health Technologies N/A N/A N/A N/A N/A

Reliq Health Technologies has lower revenue, but higher earnings than DarioHealth.

Analyst Recommendations

This is a summary of current ratings and price targets for DarioHealth and Reliq Health Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DarioHealth 1 1 1 0 2.00
Reliq Health Technologies 0 0 0 0 0.00

DarioHealth presently has a consensus target price of $9.00, suggesting a potential upside of 18.58%. Given DarioHealth’s stronger consensus rating and higher probable upside, analysts clearly believe DarioHealth is more favorable than Reliq Health Technologies.

Institutional and Insider Ownership

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 0.0% of Reliq Health Technologies shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares DarioHealth and Reliq Health Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DarioHealth -169.87% -54.81% -33.36%
Reliq Health Technologies N/A N/A N/A

Summary

DarioHealth beats Reliq Health Technologies on 6 of the 9 factors compared between the two stocks.

About DarioHealth

(Get Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

About Reliq Health Technologies

(Get Free Report)

Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.